NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra… — Class II drug recall D-0559-2022
Ongoing recall by Organics Corporation of America DBA Ambix Laboratories, reported 2022-02-23, distributed in NY. MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.
| Recall number | D-0559-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Organics Corporation of America DBA Ambix Laboratories, Totowa, NJ, United States |
| Recall initiated | 2021-12-06 |
| Classified | 2022-02-14 |
| Reported by FDA | 2022-02-23 |
| Distributed | NY |
| Quantity | 4,214 tubes |
| Reason classes | microbial contamination, sterility |
| Lot numbers | 23622 |
Product
NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, Manufactured for NaturesPlus 548 Broadhollow Road, Melville, NY 11747, USA
Reason for recall
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0559-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.